Regulatory, legal and policy aspects

Workpackage #8

Regulatory, legal and policy aspects

iCARE4CVD’s vision to pave the way to better care for individuals with
CVD could not be realised without careful insight into the regulatory, legal,
reimbursement, and policy landscape relevant to CVD. By defining a
roadmap, framework, and a strategy for biomarker and medical AI
developments that is safe, ethical, and successful, WP8 will aim to
facilitate a successful adaption and implementation of iCARE4CVD’s
medical tools.

Meet our team

Scientific Institute for Health Economics and Health Systems Research

Ines Weinhold

Manager

TNO

Gabriela Bodea , MA

Dutch Organisation for Applied Research

Decentriq

Maria Fernanda Scoz Luz

Business Development Manager

Novo Nordisk

G. Kees Hovingh

Senior Medical Officer

TNO

Willem van den Brink, PhD

Netherlands Organisation for Applied Scientific Research

Scientific Institute for Health Economics and Health Systems Research

Franziska Sende

Research associate
Get updated

Our related news

30 January, 2025

First Patient Advisory Board meeting

Today marked a significant milestone for the iCARE4CVD project, as the newly..

28 January, 2025

Launch of Patient Panels – First meeting in Dublin

In iCARE4CVD, Patient Panels are groups of individuals living with CVD who..

10 September, 2024

New publication: Evaluating digital care for heart failure using patient experience measures – A scoping review

Heart failure (heart failure) is a serious condition that affects many people..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.